Atossa Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update - Yahoo Finance
| YAG2 Stock | EUR 1.20 0.01 0.83% |
Roughly 61% of Atossa Therapeutics' investor base is looking to short. The analysis of current outlook of investing in Atossa Therapeutics suggests that many traders are alarmed regarding Atossa Therapeutics' prospects. The current market sentiment, together with Atossa Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Atossa Therapeutics stock news signals to limit their universe of possible portfolio assets.
Atossa Therapeutics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Atossa daily returns and investor perception about the current price of Atossa Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Atossa |
Atossa Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update Yahoo Finance
Read at news.google.com
 |
Atossa Therapeutics Fundamental Analysis
We analyze Atossa Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Atossa Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Atossa Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Atossa Therapeutics is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Atossa Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Atossa Therapeutics stock to make a market-neutral strategy. Peer analysis of Atossa Therapeutics could also be used in its relative valuation, which is a method of valuing Atossa Therapeutics by comparing valuation metrics with similar companies.
Peers
Atossa Therapeutics Related Equities
| ARW | Arrow Electronics | 1.80 | ||||
| LPK | LPKF Laser | 0.23 | ||||
| OIA | AOI Electronics | 0.00 | ||||
| ERT | ELECTRONIC ARTS | 0.17 | ||||
| SGM | STMicroelectronics | 0.54 |
Complementary Tools for Atossa Stock analysis
When running Atossa Therapeutics' price analysis, check to measure Atossa Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Therapeutics is operating at the current time. Most of Atossa Therapeutics' value examination focuses on studying past and present price action to predict the probability of Atossa Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Therapeutics' price. Additionally, you may evaluate how the addition of Atossa Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |